X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 101 filers reported holding X4 PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,354,070 | – | 2,413,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 1,578,947 | $3,616,000 | 1.42% |
| AIGH Capital Management LLC | 1,464,099 | $3,353,000 | 1.02% |
| Ikarian Capital, LLC | 2,264,491 | $5,186,000 | 0.77% |
| Bain Capital Life Sciences Investors, LLC | 2,886,542 | $6,610,000 | 0.52% |
| SV Health Investors, LLC | 311,490 | $713,000 | 0.46% |
| Worth Venture Partners, LLC | 340,495 | $780,000 | 0.39% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $767,000 | 0.28% |
| Sio Capital Management, LLC | 276,909 | $634,000 | 0.19% |
| BVF INC/IL | 847,879 | $1,942,000 | 0.07% |
| Orbimed Advisors | 1,373,849 | $3,146,000 | 0.04% |